KFA
PFE icon

Krane Funds Advisors’s Pfizer PFE Stock Holding History

Krane Funds Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
20,501
+267
+1% +$6.98K 0.02% 143
2026
Q1 		$567K Buy
20,234
+2,680
+15% +$71.3K 0.02% 114
2025
Q4 		$437K Sell
17,554
-2,026
-10% -$51.1K 0.01% 116
2025
Q3 		$476K Sell
19,580
-2,962
-13% -$73.1K 0.01% 94
2025
Q2 		$546K Buy
22,542
+3,625
+19% +$84.5K 0.02% 50
2025
Q1 		$479K Buy
18,917
+1,781
+10% +$46.6K 0.01% 53
2024
Q4 		$455K Sell
17,136
-1,514
-8% -$41.1K 0.02% 49
2024
Q3 		$540K Sell
18,650
-2,009
-10% -$58.6K 0.02% 43
2024
Q2 		$578K Sell
20,659
-1,172
-5% -$32.3K 0.02% 35
2024
Q1 		$602K Buy
21,831
+1,590
+8% +$44.1K 0.02% 35
2023
Q4 		$583K Buy
20,241
+1,163
+6% +$35.2K 0.02% 45
2023
Q3 		$633K Buy
19,078
+2,162
+13% +$76.5K 0.03% 40
2023
Q2 		$620K Buy
16,916
+619
+4% +$24.1K 0.03% 38
2023
Q1 		$681K Buy
16,297
+1,565
+11% +$67.6K 0.03% 43
2022
Q4 		$755K Buy
+14,732
New +$706K 0.03% 38
2022
Q3 		– Sell
-5,347
Closed -$280K – 232
2022
Q2 		$280K Sell
5,347
-2,742
-34% -$140K 0.01% 179
2022
Q1 		$419K Buy
8,089
+1,463
+22% +$75.9K 0.02% 194
2021
Q4 		$391K Sell
6,626
-2,433
-27% -$121K 0.01% 185
2021
Q3 		$390K Buy
+9,059
New +$401K 0.01% 233
2020
Q4 		– Sell
-11,238
Closed -$391K – 321
2020
Q3 		$391K Buy
+11,238
New +$394K 0.02% 139

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Krane Funds Advisors's PFE Position: Q2 2026 in Review

Krane Funds Advisors increased its Pfizer (PFE) stake by 1.3% in Q2 2026, buying an estimated $6.98K and bringing the position to 20,501 shares worth $494K. The position accounts for 0.02% of the portfolio, ranked #143.

Krane Funds Advisors first reported a position in PFE in Q3 2020 and has held it in 20 quarters since. The position peaked at $755K in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Krane Funds Advisors held 20,501 shares of Pfizer worth $494K as of Q2 2026.
  • Krane Funds Advisors bought 267 Pfizer shares in Q2 2026, an estimated $6.98K.
  • Pfizer made up 0.02% of Krane Funds Advisors's portfolio in Q2 2026, its #143 holding.
  • Krane Funds Advisors first reported a position in Pfizer in Q3 2020 and has held it in 20 quarters since.
  • Krane Funds Advisors's Pfizer position peaked at $755K in Q4 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Krane Funds Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.